Product Description: USL311 is a potent and selective CXCR4 antagonist, with anti-tumor activity. USL311 prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4[1].
Applications: Cancer-programmed cell death
Formula: C24H34N6O
References: [1]Peter Richardson. Usl-311 for use in the treatment of cancer. WO2018162924A1/[2]Takacs GP, et al. Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy. Pharmacol Ther. 2021 Jun;222:107790.
CAS Number: 1373268-67-7
Molecular Weight: 422.57
Compound Purity: 99.97
Research Area: Cancer; Endocrinology
Solubility: DMSO : 18.57 mg/mL (ultrasonic;warming;heat to 80°C)